Related Experiment Videos
Adjuvant therapy for resectable breast cancer
1Department of Medicine, Cornell University Medical College, New York, New York, USA.
Hematology/Oncology Clinics of North America
|June 11, 1999
Summary
Breast cancer survival is improving due to early detection and better treatments. Optimizing hormone therapy and chemotherapy is key to preventing recurrence and secondary cancers.
Area of Science:
- Oncology
- Medical Treatment
Background:
- Breast cancer mortality rates are declining.
- Improvements are attributed to early detection, surgical and radiation therapy advancements, and enhanced systemic therapy effectiveness.
Purpose of the Study:
- To discuss the evolving challenges in integrating and applying breast cancer treatment modalities.
- To highlight the rapid advancements in systemic therapy, including new drugs and regimens.
Main Methods:
- Review of recent studies on breast cancer treatment outcomes.
- Analysis of the role of hormone therapy and chemotherapy in preventing relapse and second primary tumors.
Main Results:
- Optimal outcomes may be achieved through judicious use of hormone therapy and chemotherapy.
- These systemic therapies show potential in preventing cancer relapse and the development of second primary tumors.
Conclusions:
- The choice of breast cancer therapy requires careful, individualized consideration.
- Effective management involves integrating early detection, refined local therapies, and optimized systemic treatments.